Stifel Likes The Setup in Dicerna Pharma (DRNA) Shares

March 9, 2018 7:12 AM

Stifel analyst, Stephen Willey, reiterated his Buy rating on shares of Dicerna Pharmaceuticals (NASDAQ: DRNA) and raised his price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found